Nevertheless, these authors demonstrated that YM155 treatment decreases survivin expression in the tumor at both Day 3 and Day 7 time points tested when administrating via the 3-day continuous infusion at 10 mg/kg [39]. This evidence concerns the gene BIRC5 and neoplasm.